An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results.

K Aaron Geno Adina Badea Kara L LynchPaul JannettoJacqueline A HubbardRobert D NerenzMark A Cervinski

Published in: The journal of applied laboratory medicine (2022)

Laboratories using these assays should be aware of the potential for false-positive screening results due to the presence of high concentrations of loperamide and its metabolite dLop.

Keyphrases

chronic pain
high glucose
diabetic rats
high throughput
sensitive detection
drug induced
oxidative stress
endothelial cells
quantum dots